Correction to: The impact of COVID-19 pandemic on treatment adherence of patients with breast cancer (Supportive Care in Cancer, (2025), 33, 7, (552), 10.1007/s00520-025-09582-8)

Nurit Betzer Lavee; Micha Barchana; Tuvia Baevsky; Israel Yoles

doi:10.1007/s00520-025-09724-y

Correction to: The impact of COVID-19 pandemic on treatment adherence of patients with breast cancer (Supportive Care in Cancer, (2025), 33, 7, (552), 10.1007/s00520-025-09582-8)

Nurit Betzer Lavee
, Micha Barchana
, Tuvia Baevsky
, Israel Yoles

Research output: Contribution to journal › Comment/Debate

Abstract

In the last cell of the Table 1 (row 19, column 2), the value appears as 206 instead of the correct number 2067. (Table presented.) Participant sociodemographic and behavioral characteristics Variable Total (N = 4,274) Median 68.25 Range 29–98 20–40 98 (2%) 40–60 950 (20%) 60–80 2,824 (61%) > 80 773 (17%) Anastrozole 148 (3%) Exemestane 31 (1%) Letrozole 1,260 (27%) Tamoxifen 3,206 (69%) Low 338(7%) Medium 3,397 (73%) High 910 (20%) Yes 1667 (39%) No 2607(61%) Yes 3, 978(93%) No 299 (7%) *As determined by the ICBS cluster analysis formula [22] The correct Table 1 is shown below. The original article has been corrected.

Original language	English
Article number	675
Journal	Supportive Care in Cancer
Volume	33
Issue number	8
DOIs	https://doi.org/10.1007/s00520-025-09724-y
State	Published - Aug 2025
Externally published	Yes

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s00520-025-09724-y

Cite this

@article{088d49ea833b4dba8da6eb1d7dd1b7f1,

title = "Correction to: The impact of COVID-19 pandemic on treatment adherence of patients with breast cancer (Supportive Care in Cancer, (2025), 33, 7, (552), 10.1007/s00520-025-09582-8)",

abstract = "In the last cell of the Table 1 (row 19, column 2), the value appears as 206 instead of the correct number 2067. (Table presented.) Participant sociodemographic and behavioral characteristics Variable Total (N = 4,274) Median 68.25 Range 29–98 20–40 98 (2\%) 40–60 950 (20\%) 60–80 2,824 (61\%) > 80 773 (17\%) Anastrozole 148 (3\%) Exemestane 31 (1\%) Letrozole 1,260 (27\%) Tamoxifen 3,206 (69\%) Low 338(7\%) Medium 3,397 (73\%) High 910 (20\%) Yes 1667 (39\%) No 2607(61\%) Yes 3, 978(93\%) No 299 (7\%) *As determined by the ICBS cluster analysis formula [22] The correct Table 1 is shown below. The original article has been corrected.",

author = "Lavee, \{Nurit Betzer\} and Micha Barchana and Tuvia Baevsky and Israel Yoles",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = aug,

doi = "10.1007/s00520-025-09724-y",

language = "English",

volume = "33",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "8",

}

TY - JOUR

T1 - Correction to

T2 - The impact of COVID-19 pandemic on treatment adherence of patients with breast cancer (Supportive Care in Cancer, (2025), 33, 7, (552), 10.1007/s00520-025-09582-8)

AU - Lavee, Nurit Betzer

AU - Barchana, Micha

AU - Baevsky, Tuvia

AU - Yoles, Israel

PY - 2025/8

Y1 - 2025/8

N2 - In the last cell of the Table 1 (row 19, column 2), the value appears as 206 instead of the correct number 2067. (Table presented.) Participant sociodemographic and behavioral characteristics Variable Total (N = 4,274) Median 68.25 Range 29–98 20–40 98 (2%) 40–60 950 (20%) 60–80 2,824 (61%) > 80 773 (17%) Anastrozole 148 (3%) Exemestane 31 (1%) Letrozole 1,260 (27%) Tamoxifen 3,206 (69%) Low 338(7%) Medium 3,397 (73%) High 910 (20%) Yes 1667 (39%) No 2607(61%) Yes 3, 978(93%) No 299 (7%) *As determined by the ICBS cluster analysis formula [22] The correct Table 1 is shown below. The original article has been corrected.

AB - In the last cell of the Table 1 (row 19, column 2), the value appears as 206 instead of the correct number 2067. (Table presented.) Participant sociodemographic and behavioral characteristics Variable Total (N = 4,274) Median 68.25 Range 29–98 20–40 98 (2%) 40–60 950 (20%) 60–80 2,824 (61%) > 80 773 (17%) Anastrozole 148 (3%) Exemestane 31 (1%) Letrozole 1,260 (27%) Tamoxifen 3,206 (69%) Low 338(7%) Medium 3,397 (73%) High 910 (20%) Yes 1667 (39%) No 2607(61%) Yes 3, 978(93%) No 299 (7%) *As determined by the ICBS cluster analysis formula [22] The correct Table 1 is shown below. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/105010839984

U2 - 10.1007/s00520-025-09724-y

DO - 10.1007/s00520-025-09724-y

M3 - Comment/Debate

C2 - 40634806

AN - SCOPUS:105010839984

SN - 0941-4355

VL - 33

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 8

M1 - 675

ER -

Correction to: The impact of COVID-19 pandemic on treatment adherence of patients with breast cancer (Supportive Care in Cancer, (2025), 33, 7, (552), 10.1007/s00520-025-09582-8)

Abstract

Bibliographical note

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this